← FDA Drug Approvals (Drugs@FDA)

DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA · Approved 2023-11-17

Drug application

FDA Application #

ANDA215049

Application type

Abbreviated New Drug Application (Generic)

Brand name

DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM

Generic name

DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM

Active ingredients

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Dosage form

SOLUTION

Route

ORAL, RECTAL

Marketing status

Prescription

Sponsor

ANNORA PHARMA

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2023-11-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown